Seward simplifies cell preparation

Published: 31-May-2011
Manufacturing

Enhances applications for Strainer bags to include sterile processing of tissue samples

Seward Limited, the UK manufacturer of the Stomacher paddle blenders and accessories used in sample preparation for microbiological analyses, has further enhanced the applications for its Strainer bags to include sterile processing of tissue samples for primary cell preparation.

Gamma irradiated sterile and available in a range of sizes, the Strainer bags are compatible with all laboratory paddle blenders, including Seward’s Stomacher 80 Biomaster series. Because they are fully containable and easily used in a sterile environment, the Strainer bags can be used for new applications in cell culture.

The 0.5mm pore size of the integrated strainer element within the Seward Strainer bag generates a uniformly homogenous cell suspension, says the Worthing-based company. This allows the cells’ passage through the pores of the central straining matrix and prevents contamination with undigested extracellular material, which can block pipettes. Produced to provide a sterile, secure environment for the preparation of single cell suspensions, the Strainer bag is suitable for the individual processing of a large number of samples.

“The new life-science applications of our robust Strainer bag technology represent the continuing, customer oriented, development to which Seward is committed,” said Stuart Ray, technical director at Seward Ltd.

“Cell scientists can simplify their primary culture preparations by straining the processed tissues to ensure trouble-free pipetting, whilst also increasing the viability of the cells produced as the end product.”

See more

You may also like

Manufacturing

Seward moves to new premises

Read more
Doubles manufacturing and storage facilities

Trending Articles

  1. Compact, economical and sustainable cooling solutions for laboratories Huber Unichillers offer space-saving and environmentally friendly temperature control for research and industrial applications
  2. Aragen to manufacture Renaissance Pharma’s FDA Fast Track mAb as part of ongoing strategic collaboration CRDMO successfully scaled and transferred Renaissance Pharma’s lead candidate, Daretabart a humanised monoclonal antibody targeting GD2 for high-risk neuroblastoma, in just 9 months
  3. Bruker announces major strides in 4D proteomics performance, further advances In intact and top-down functional proteoform analysis, and innovations in hybrid qual/quant 4D metabolomics All to enable deeper insights into disease biology. Bruker Also Launches Two Novel Mass Spectrometry Systems for Unique Applications in Energy Industry Research, and in Semiconductor Manufacturing
  4. CEPI fast-tracks three Bundibugyo ebolavirus vaccine candidates amid DRC outbreak With no licensed vaccines available and more than 900 suspected cases already recorded, CEPI is urgently advancing mRNA, rVSV and viral vector candidates from Moderna, IAVI and Oxford/SII toward clinical trials
  5. FDA Form 483 flags falsified records and live bird infestation at Dabur India OTC plant A FDA inspection report issued in January 2026 has revealed widespread CGMP failures at Dabur India's Dadra and Nagar Haveli facility, including manipulated microbiology data, fraudulent equipment logs and unsanitary storage conditions

Upcoming event

BIO International Convention

22–25 June 2026 | Convention | Boston, US See all

You may also like

Manufacturing

Seward moves to new premises

Doubles manufacturing and storage facilities
Manufacturing

Lonza appoints Hans Trees as Global Head of Communications

Hans Trees will join Lonza as Global Head of Communications, Senior Vice President and Member of the Extended Executive Committee, effective 1 September 2026. Hans combines deep industry experience with a strong track record in stakeholder engagement, most recently serving as Global Head of External Engagement at Roche
Manufacturing

AlzeCure licenses Alzheimer’s candidate ACD680 to Lilly in deal worth up to $1bn

AlzeCure Pharma has entered a global licensing and collaboration agreement with Eli Lilly for its Alzheimer's disease candidate ACD680, securing a $10m upfront payment and potential milestone payments exceeding $1bn
Manufacturing

Safety in pharmaceutical manufacturing: why a trusted partner makes all the difference

By taking a three-tiered approach to protecting patients and personnel and ensuring plant compliance, GEA adopts a consultative approach to helping its customers navigate the responsibilities of pharmaceutical manufacturing safety with confidence
Manufacturing

Aragen to manufacture Renaissance Pharma’s FDA Fast Track mAb as part of ongoing strategic collaboration

CRDMO successfully scaled and transferred Renaissance Pharma’s lead candidate, Daretabart a humanised monoclonal antibody targeting GD2 for high-risk neuroblastoma, in just 9 months
Manufacturing

Cutting-edge wiped film evaporator installation – non-tobacco nicotine products

Successful system installation for a UK research and development facility developing and commercialising non-tobacco nicotine products using industry-leading evaporation equipment
Manufacturing

Next expansion milestone achieved: SCHOTT Pharma opens production facility in Serbia to strengthen competitiveness in Europe

After a double-digit million euro investment and less than 1.5 years of construction, SCHOTT Pharma opens new manufacturing site in Jagodina, Serbia. Production capacity to meet European market demand for pharmaceutical ampoules. Facility brings around 180 new jobs to the region
Subscribe now